Opportunities

Jhpiego, an international non-profit health organization affiliated with Johns Hopkins University, has been a global leader in advancing maternal and child health for over 50 years across 150+ countries. Committed to preventing needless deaths and improving healthcare systems, Jhpiego partners with governments, civil society, and communities to drive evidence-based interventions. Through Gavi funding, Jhpiego is providing technical assistance for the rollout of the HPV vaccine in Pakistan, supporting national and provincial stakeholders in ensuring effective implementation.

Background The Reaching Impact Saturation and Epidemic Control (RISE) program is saving lives and improving health by controlling the HIV pandemic and strengthening global health security to limit the spread of deadly disease outbreaks. RISE uses evidence-based practices from over 20 years of PEPFAR implementation to address critical HIV priorities along with global health security (GHS), maternal, newborn, and child health and Nutrition (MNCH-N), tuberculosis (TB), Malaria, data systems, supply chain and commodity management, and other cross-cutting areas.

Background   The Reaching Impact Saturation and Epidemic Control (RISE) program is saving lives and improving health by controlling the HIV pandemic and strengthening global health security to limit the spread of deadly disease outbreaks. RISE uses evidence-based practices from over 20 years of PEPFAR implementation to address critical HIV priorities along with global health security (GHS), maternal, newborn, and child health and Nutrition (MNCH-N), tuberculosis (TB), Malaria, data systems, supply chain and commodity management, and other...

Jhpiego is an international non-profit health organization affiliated with Johns Hopkins University, USA. For more than 50 years and in over 150 countries, Jhpiego has worked to prevent the needless deaths of women and their families. Jhpiego is dedicated to improving the health of women and families in developing countries. Jhpeigo is seeking a Finance Specialist who will support the Sound Financial Management of Jhpiego Projects. This Position will ensure that financial systems are compatible with standard accounting practices and Donor, Jhpiego and John...

O Assessor de M&A/SI apoiará o desenho de processos, mecanismos e ferramentas para a identificação, recolha, armazenamento, processamento e apresentação de dados sobre os indicadores do Projecto. Ele apoiará as equipas técnicas em todos os processos de aprendizagem pela implementação.

Jhpiego is an international, non-profit health organization and an affiliate of Johns Hopkins University, dedicated to improving the health of women and families in developing countries. For over 50 years, it has focused on providing high-quality, low-cost health care solutions, training health workers, and strengthening health systems. Jhpiego has been working in India since the 1980s in close partnership with national and state governments. With deep technical expertise and strong...

Jhpiego seeks a Project Director (PD) to provide vision, leadership, and technical and financial stewardship for a Unitaid funded, multi-country investment focused on accelerating cervical cancer secondary prevention in LMICs. The $30M, 3–5year project will support countries to accelerate from smaller initiatives to sustainable, nationally owned, integrated services aligned with WHO elimination targets (≥70% screening; ≥90% treatment), with an emphasis on equity, accessibility, and innovation (e.g., next generation HPV diagnostics, AI supported visual evaluation, digital referral/retention solutions), and resilient supply and delivery systems (including pooled models and...

Jhpiego seeks a Monitoring, Evaluation, Learning and Research (MERL) Director to provide strategic, technical, and methodological leadership for a Unitaid-funded, multi‑country initiative focused on accelerating cervical cancer secondary prevention in LMICs. The project aims to support countries to establish routine, integrated screening and treatment services, introduce and evaluate innovative tools (e.g., next‑generation HPV diagnostics, AI‑enhanced visual evaluation, digital referral/retention systems), generate actionable evidence, strengthen supply and delivery systems, and advance equity, sustainability, and national ownership. The MERL Director will lead the design and execution...

Malaria remains a major public health threat in Africa, causing hundreds of thousands of deaths annually. Artemisinin-based combination therapies (ACTs) are the cornerstone of malaria treatment, but the emergence of antimalarial drug resistance, including partial resistance to artemisinin and partner drugs poses a serious risk to malaria control gains. Currently, there is no resistance in Nigeria, however, if resistance sets in; it will be catastrophic. The National Malaria Elimination Programme (NMEP) in collaboration with Jhpiego (Johns Hopkins University affiliate) is implementing Scaling the Optimal...

Postpartum Hemorrhage (PPH) remains the leading cause of maternal mortality in Nigeria. In response to Nigeria’s national PPH manual finalized and disseminated in April 2024, and the WHO Consolidated guidelines for the prevention, diagnosis and treatment of postpartum haemorrhage (5 October 2025), the Federal Ministry of Health and Social Welfare (FMoH&SW) will update national guidance and tools to reflect current global recommendations and Nigeria’s implementation learning. Significant clinical advancements, including the E-MOTIVE bundle (Early detection using calibrated drapes, Massage, Oxytocics, Tranexamic Acid, IV fluids, and Examination), the introduction of Heat-Stable...